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S U M M A R Y
Objectives: Malaria is considered to have been eradicated in Greece and only sporadic cases in travelers
are reported. However the migration of populations from endemic countries of Asia to Greece may have
caused a re-emergence of the disease.
Methods: A cluster of nine human malaria cases due to Plasmodium vivax infection in the area of Laconia
(southern Peloponnesus) from 2009 to 2010 is presented. Patients were hospitalized in Sparta General
Hospital.
Results: Eight patients were diagnosed in 2009 and one in 2010. Two were refugees from Pakistan and
Afghanistan and ﬁve were Romas living in a local camp. Apart from the two immigrants, no other patient
had any history of travel, blood transfusion, or organ transplantation. All patients had a febrile illness,
hematological abnormalities, and irregular liver function tests. Parasites were identiﬁed in peripheral
blood smears, and PCR conﬁrmed the presence of P. vivax. Sensitivity testing showed chloroquine
susceptibility. Combined treatment with chloroquine followed by primaquine was completed
uneventfully. Entomological surveillance disclosed the presence of Anopheles saccharovi as the
predominant mosquito species, however PCR testing failed to identify P. vivax in the mosquito
population.
Conclusions: We have presented the ﬁrst large outbreak of the local transmission of autochthonous
malaria cases in Greece since the 1950s. Enhanced entomological surveillance and early detection of
malaria cases are crucial in order to prevent the re-emergence of malaria, not only in Greece, but in
Europe as well.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Malaria is the most prevalent vector-borne disease in the
world.1 In 2008, there were an estimated 243 million (5th–95th
percentile, 190–311 million cases) cases of malaria worldwide. The
vast majority of cases (85%) were reported from the African region,
followed by the South-East Asia region (10%) and the Eastern
Mediterranean region (4%).2 The global incidence of malaria due to
Plasmodium vivax is estimated at approximately 70–80 million
cases annually, while P. vivax is considered the second most
common of the Plasmodium species causing human disease.3
Approximately 10–20% of the world’s cases of P. vivax infection
occur in Sub-Saharan Africa. P. vivax is causally associated with
approximately 10% of malaria cases in Eastern and Southern Africa,
but less than 1% of cases in Western and Central Africa. Outside of* Corresponding author. Tel.: +30 697 3399814; fax: +30 273 1029006.
E-mail address: ermanitari@hotmail.com (P. Andriopoulos).
1201-9712/$36.00 – see front matter  2012 International Society for Infectious Disea
http://dx.doi.org/10.1016/j.ijid.2012.09.009the African continent, P. vivax accounts for more than 50% of all
malaria cases; 80–90% of such cases occur in the Middle East, Asia,
and the Western Paciﬁc, mainly in the tropical regions, and 10–15%
in Central and South America.4
Malaria is considered by the World Health Organization (WHO)
to have been eradicated in Europe. It was endemic in Greece until
1973, at which time the country was declared malaria-free.5
Malaria is a reportable disease in Greece and is included in the
national mandatory notiﬁcation system. An increase in non-
autochthonous malaria cases has been recorded from 1998
onwards in Greece (less than 50 cases in total), which reﬂects
cases imported through non-screened migrants.6 Sustained local
transmission had not been identiﬁed prior to the detection of the
cases reported herein.
We present a cluster of nine human infections with P. vivax
malaria occurring in the southern Greek peninsula of Peloponnesus
and more speciﬁcally in the area of Laconia. Eight cases were
hospitalized in the Sparta General Hospital, Laconia Greece in 2009
and one in 2010. This case-series represents the ﬁrst large outbreakses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Time trend of the malaria cluster during the outbreak, August–October
2009.
P. Andriopoulos et al. / International Journal of Infectious Diseases 17 (2013) e125–e128e126of local transmission of autochthonous malaria cases in Greece
since the 1950s.
2. Materials and methods
Eight patients were admitted to the Internal Medicine
Department of the Sparta General Hospital between August 5
and October 11, 2009 with non-speciﬁc symptoms of a febrile
illness: fever, malaise, abdominal pain, and mild jaundice. The ﬁrst
patient was an immigrant from Afghanistan who lived in Sparta,
and who reported prior treatment for malaria with chloroquine for
3 days while in Afghanistan a year ago. The second patient was an
immigrant from Pakistan who had been living in a small village
called Skoutari (approximately 50 kilometers south of Sparta) for
the past 4 months, since his arrival from Pakistan. The third patient
was a Roma living in a camp situated in the area of Skala, Laconia,
30 km southeast of Sparta. During the 6 weeks that followed the
initial presentation of these three patients, ﬁve more patients were
admitted with similar symptoms to the same hospital; two
inhabitants of Skala and a village called Glykovrisi (situated 10 km
from Skala) and three more Romas from the same camp where the
third patient lived. All of these patients resided or worked during
the summer in the ﬁelds of Skala near the Eurotas River, in an area
called ‘Elos’, which in Greek means swamp.
After the diagnosis of P. vivax malaria was established for the
ﬁrst patient, the Hellenic Center for Disease Control and Prevention
(HCDCP) was notiﬁed and an enhanced surveillance system was
implemented in order to evaluate, control, and prevent the disease.
Any patient living in the area and seeking medical care for a
persistent febrile illness during the period of August to November
2009 was suspected of malaria infection. The identiﬁcation of
parasites in peripheral blood smears was considered diagnostic for
malaria. Since malaria is a reportable disease in Greece, an HCDCP
questionnaire was completed; when no history of travel, blood
transfusion, or organ transplantation, or prior infection was
mentioned, the case was considered autochthonous. Blood
donation in the area was suspended and close contacts of the
patients were examined. An entomological survey was conducted
in the region to examine the presence of Anopheles mosquito
species and to identify any pools of infection within that mosquito
population. Water samples containing larvae were collected from
the river irrigating the area, and traps were used to collect adultFigure 2. A spot map showing the area of residence of the casesmosquitoes. Blood samples for all patients were sent to the Athens
School of Public Health for conﬁrmation of the Plasmodium species
by a previously described PCR-based method.7 Sensitivity tests
were also performed to evaluate susceptibility of the P. vivax strain
to the antimalarial agent chloroquine. A year later (July 2010)
another Roma from the same camp presented with similar
symptoms.
3. Results
3.1. Clinical and epidemiological data
Figure 1 illustrates the distribution of cases over time and the
short time trend associated with this cluster in 2009. Figure 2
depicts a spot map of the cases. The median age of the patients
from both 2009 and 2010 was 45.2 years.
Laboratory values on presentation for all patients are shown in
Table 1. All presented with mild hemolytic anemia and neutrope-
nia, and also thrombocytopenia, which is not a common ﬁnding in
P. vivax malaria.3 All had an elevated erythrocyte sedimentation
rate and C-reactive protein, mild jaundice, and abnormal liver in the region of the cluster of Plasmodium vivax infections.
Table 1
Clinical and laboratory data of the affected patients. Data are presented as the
median (range) unless otherwise indicated.
Age 45.2 (24–65)
Gender, male, n (%) 6 (67%)
Hematocrit (%) 32.1 (25–36)
Hemoglobin (g/dl) 10.7 (9.2–11.1)
White blood cells (109/l) 3.258 (3.105–3.250)
Platelets (109/l) 63.500 (56.000–72.500)
Erythrocyte sedimentation rate (mm/h) 37.5 (31.5–47.2)
C-reactive protein (mg/dl) 10.98 (7.4–14.5)
Lactate dehydrogenase (U/l) 867.87 (547–1012)
Aspartate aminotransferase (U/l) 73.5 (42–96)
Alanine aminotransferase (U/l) 78 (54–98)
Alkaline phosphate (U/l) 110.5 (95–114)
g-Glutamyltransferase (U/l) 65.87 (35–89)
Total bilirubin (mg/dl) 2.15 (1.5–3.5)
Direct bilirubin (mg/dl) 0.6 (0.2–0.9)
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patients exhibited tertian fever. Diagnosis was made after
examination of peripheral blood smears, which revealed parasites
consistent with P. vivax malaria. Typing was performed using a
PCR. Sensitivity tests showed that all the strains were chloroquine-
sensitive. Patients were tested and all had normal levels of glucose-
6-phosphate dehydrogenase. They were treated with a combined
regimen of chloroquine followed by primaquine, in accordance
with the US Centers for Disease Control and Prevention (CDC)
protocol for the treatment of P. vivax malaria.8 All patients made a
rapid clinical recovery and laboratory results returned to normal
within the ﬁrst week after treatment. No patient required
admission to an intensive care unit. Follow-up after the completion
of treatment revealed no parasites in the peripheral blood.
Blood donation in the area was suspended until December
2009. Thirty-ﬁve blood samples were collected from the residents
of the Roma camp where the Roma patients lived, as well as from
the seven Pakistanis who were close contacts of the second patient
residing in Skoutari. All these samples tested negative for the
presence of Plasmodium spp, both by blood smear examination and
by PCR. No other case was reported in 2010, but in 2011 a new
cluster of malaria cases occurred and another intervention
program was implemented.9
3.2. Entomological data
The mosquito monitoring data collected in the area with the
insect traps and the examination of water samples showed that
Anopheles saccharovi was the predominant (80%) mosquito
population in the area. PCR testing of the mosquito population
disclosed no infestation of any of the adult mosquitoes or larvae.
An enhanced entomological surveillance system remained opera-
tional in the area for the next 2 years with no infected mosquitoes
until September 2011,9 when a new cluster of cases occurred.
3.3. Ecological parameters
The area in Laconia where the patients lived or worked was the
delta of the Eurotas and Vassilopotamos rivers. The place was
originally called ‘Elos’, which in Greek means swamp. Agriculture
is the main occupation, relying on water channels from these
rivers, which tend to dry out in the summer making the conditions
favorable for potential malaria vectors such as mosquitoes.
4. Discussion
We report the ﬁrst outbreak of autochthonous malaria cases
(according to the deﬁnition of the WHO) since 1973 in the area ofLaconia, in the Peloponnesus peninsula in southern Greece. This
outbreak occurred in 2009. In total, eight cases of malaria were
notiﬁed from the area between August and December 2009 and
one in July 2010. The ﬁrst two cases were refugees from countries
where malaria is endemic (imported cases) and the majority of the
other cases involved Romas living in a camp situated close to a
local river (autochthonous cases). Evidence of local transmission of
the pathogen was found within the closed population of the Roma
camp, and also none of the other patients had a history of travel to
endemic countries or other possible exposure. Microbiological
testing of samples collected from camp inhabitants as well as
samples from the local circulating mosquito population were
negative. Greece was declared malaria-free by the WHO in 1973;
this is the ﬁrst time since then that the local transmission of
malaria has occurred in our country.
Before the introduction of antimalarial drugs, P. vivax malaria
caused a chronic disabling disease that reduced the average life
span, and was endemic in Europe, North America, and the
tropics.10 The clinical presentation of the disease is associated
with non-speciﬁc symptoms such as chills, vomiting, malaise,
headache, myalgias, fever, and diarrhea, which complicate the
differential diagnosis of P. vivax malaria from other febrile
illnesses,6 or other malaria infections.11 High fever and rigors
are more common in P. vivax than Plasmodium falciparum malaria,
reﬂecting synchronicity of schizont rupture. The classic parox-
ysms of fever lasting 4–8 h and occurring with a 48–56 h
periodicity, take several asexual cycles to develop in primary
infections, although relapses often start synchronously with
rigors.12 The most common ﬁnding on clinical examination is
enlargement of the spleen. Compared to P. falciparum, P. vivax has
a slightly longer incubation period (12 days to several months), a
similar erythrocytic cycle (42–48 h), and produces fewer mer-
ozoites per schizont.13 Infection associated with P. vivax is rarely
fatal; however relapses often occur months to years after the
primary infection due to dormant parasites in the liver. Cases of
malaria similar to the ones presented herein may become of
growing concern in Europe, since populations migrating from Asia
to Europe living in poor sanitary conditions may be involved in the
propagation of outbreaks due to local transmission.14–16 In-
creased vector access to such a population is another potential
scenario. Other potential reasons include the expansion of the
vector populations in speciﬁc geographic areas whenever the
climatic conditions are appropriate. Indeed the continuous arrival
of refugees from endemic countries probably led to the new
cluster in 2011.9,17,18 The ﬁrst report was a Romanian worker in
the area of Skala who returned to his home country after the
febrile illness,17 and in the following months further cases and a
much bigger cluster occurred.9,18 As a result the WHO was notiﬁed
again and an enhanced surveillance system was implemented,9
since Greece is on the southern border of Europe and has been
handling an increasing number of immigrants coming to the
country each year – refugees from Asian countries that are
malaria-endemic (Afghanistan and Pakistan) according to the
WHO.19–21
In conclusion, we present the ﬁrst local cluster of autochtho-
nous cases of malaria due to P. vivax in the area of Laconia over the
last four decades. We believe that this outbreak may have
important public health implications. Enhanced surveillance of
the mosquito population and the application of vector control
measures (preferably within an integrated vector management
project), as well as the early detection of malaria cases through
awareness and education of clinicians in areas where autochtho-
nous malaria cases appear, are crucial in order to prevent the re-
emergence of malaria, not only in Greece, but in other European
countries as well.
Conﬂict of interest: No conﬂict of interest to declare.
P. Andriopoulos et al. / International Journal of Infectious Diseases 17 (2013) e125–e128e128References
1. Sachs J, Malaney P. The economic and social burden of malaria. Nature
2002;415:680–5.
2. World Health Organization. World Malaria Report 2009. Geneva: WHO; 2009.
p. 27–54.
3. Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium
vivax malaria. Am J Trop Med Hyg 2001;64(1–2 Suppl):97–106.
4. World Health Organization/Global Malaria Programme. Roll Back Malaria.
World malaria report 2005. Malaria burden. Available at: http://www.
rollbackmalaria.org/wmr2005/html/1-2.htm (accessed November 4, 2010).
5. World Health Organization. Synopsis of the world malaria situation in 1979.
Wkly Epidemiol Rec 1981;56:145–9.
6. Economopoulou A, Andreopoulou A, Pavli A. Descriptive analysis of malaria
cases in Greece 1998–2008. Presented at the 11th Conference of the Interna-
tional Society of Travel Medicine, Budapest, Hungary, May 24–28, 2009.
7. Patsoula E, Spanakos G, Soﬁanatou D, Parara M, Vakalis NC. A single-step, PCR
based method for the detection and differentiation of Plasmodium vivax and
Plasmodium falciparum. Ann Trop Med Parasitol 2003;97:15–21.
8. US Centers for Disease Control and Prevention. Malaria Diagnosis and treatment
in the United States. Available at: http://www.cdc.gov/malaria/resources/pdf/
treatmenttable.pdf (accessed November 4, 2012).
9. Danis K, Baka A, Lenglet A, Van Bortel W, Terzaki I, Tseroni M, et al. Autochtho-
nous Plasmodium vivax malaria in Greece, 2011. Euro Surveill 2011;16. pii:
19993.
10. Sina B. Focus on Plasmodium vivax. Trends Parasitol 2002;18:287–9.
11. Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A. Plasmodium vivax
malaria. Emerg Infect Dis 2005;11:132–4.12. Collins WE, Jeffery GM, Roberts JM. A retrospective examination of reinfection
of humans with Plasmodium vivax. Am J Trop Med Hyg 2004;70:642–4.
13. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria:
neglected and not benign. Am J Trop Med Hyg 2007;77(6 Suppl):79–87.
14. Mu¨hlberger N, Jelinek T, Gascon J, Probst M, Zoller T, Schunk M, et al. Epidemi-
ology and clinical features of vivax malaria imported to Europe: sentinel
surveillance data from TropNetEurop. Malar J 2004;3:5.
15. Millet JP, Garcia de Olalla P, Carrillo-Santisteve P, Gasco´n J, Trevin˜o B, Mun˜oz J,
et al. Imported malaria in a cosmopolitan European city: a mirror image of the
world epidemiological situation. Malar J 2008;7:56.
16. Ponc¸on N, Tran A, Toty C, Luty AJ, Fontenille D. A quantitative risk assessment
approach for mosquito-borne diseases: malaria re-emergence in southern
France. Malar J 2008;7:147.
17. Florescu SA, Popescu CP, Calistru P, Ceausu E, Nica M, Toderan A, et al.
Plasmodium vivax malaria in a Romanian traveller returning from Greece,
August 2011. Euro Surveill 2011;16. pii: 19954.
18. Loupa CV, Tzanetou K, Kotsantis I, Panopoulos S, Lelekis M. Autochthonous
Plasmodium vivax malaria in a Greek schoolgirl of the Attica region. Malar J
2012;11:52.
19. Illegal immigration in Greece. Border burden: Greece struggles to deal with a
European problem. Economist; August 19, 2010. Available at: http://www.
economist.com/node/16847278 (accessed May 5, 2012).
20. Research Institute for European and American Studies. Immigration to Greece
(March 2012). RIEAS; April 14, 2012. Available at: http://www.rieas.gr/
research-areas/illegal-immigration/1746-immigration-to-greece-march-
2012.html (accessed May 5, 2012).
21. US Centers for Disease Control and Prevention. CDC malaria map application.
Available at: http://cdc-malaria.ncsa.uiuc.edu/ (accessed May 5, 2012).
